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Summary
The mechanisms controlling the differentiation of
dendritic cells (DCs) remain largely unknown. Using
a transcriptional profiling approach, we identified Gfi1
as a novel critical transcription factor in DC differenti-
ation. Gfi1−/− mice showed a global reduction of my-
eloid and lymphoid DCs in all lymphoid organs
whereas epidermal Langerhans cells were enhanced
in number. In vivo, Gfi1−/− DCs showed striking phe-
notypic and functional alterations such as defective
maturation and increased cytokine production. In vi-
tro, Gfi1−/− hematopoietic progenitor cells were un-
able to develop into DCs. Instead, they differentiated
into macrophages, suggesting that Gfi1 is a critical
modulator of DC versus macrophage development.
Analysis of hematopoietic chimeras and retrovirus-
reconstituted hematopoietic progenitor cells estab-
lished a cell autonomous and nonredundant role for
Gfi1 in DC development. The developmental defect of
Gfi1−/− progenitor cells was associated with de-
creased STAT3 activation. In conclusion, we have
identified Gfi1 as a critical transcription factor that
controls DC versus macrophage development and
dissociates DC maturation and activation.
Introduction
Dendritic cells (DCs) play a crucial role in the control of
the adaptive and innate immune system. Over the last
few years, it has become apparent that the DC com-
partment comprises functionally diverse cell popula-
tions with unique properties. Several subpopulations of
DCs have been described based on the expression of
cell surface markers, functional characteristics and an-
atomical localization. Murine CD11c+ DCs can be clas-
sified into CD8α+ and CD8α− DCs (Anjuere et al., 1999;
Vremec et al., 1992). CD8α− DCs can be further subdi-*Correspondence: klein.christoph@mh-hannover.devided into CD4−CD8α− and CD4+CD8α− subsets (Martin
et al., 2000). In addition, CD11c+B220+ DCs have been
described as counterparts of human plasmacytoid DCs,
producing interferon-α in response to viral infections
(Asselin-Paturel et al., 2001).
Despite the phenotypic characterization of diverse
DC subpopulations, their developmental pathways of
differentiation from hematopoietic stem cells (HSCs) re-
main poorly defined (Ardavin, 2003). HSC differentiation
results in the separation of a lymphoid and myeloid
pathway, reflected in the generation of committed com-
mon lymphoid and common myeloid progenitor cells
(Kondo et al., 2003). Early concepts postulated the
existence of CD8α+ lymphoid DCs and CD8α− myeloid
DCs, originating from common lymphoid progenitors
and common myeloid progenitors, respectively (An-
juere et al., 1999; Vremec et al., 1992; Wu et al., 1996).
This conceptual dichotomy was challenged by findings
from different groups that myeloid progenitor cells can
give rise to “lymphoid” DCs and that lymphoid progeni-
tor cells can give rise to “myeloid” DCs (Manz et al.,
2001; Martin et al., 2000; Traver et al., 2000). More re-
cently, committed DC progenitor cells have been iden-
tified in bone marrow and peripheral blood (D’Amico
and Wu, 2003; del Hoyo et al., 2002). Thus, a more de-
tailed description of specific developmental stages in
hematopoietic and DC development has become pos-
sible.
The lineage fate of hematopoietic progenitor cells is
controlled by an orchestrated expression pattern of
transcription factors, yet the precise molecular mecha-
nisms how these factors govern the diversification of
dendritic cell progenitor cells remain largely unknown.
The analysis of gene-targeted mice has revealed the
functional importance of a few critical transcription
factors for DC development. Mice lacking RelB (Wu et
al., 1998), PU.1 (Guerriero et al., 2000), and Ikaros (Wu
et al., 1997) show reduced numbers of CD8α− DCs,
whereas mice lacking IRF4 (Suzuki et al., 2004), IRF8
(Schiavoni et al., 2002), and Id2 (Hacker et al., 2003)
exhibit a defect in the development of CD8α+ DCs.
STAT3 activation has been identified as a crucial check-
point of Flt3L-regulated DC development. In STAT3−/−
hematopoiesis the numbers of common DC precursors
as well as their DC progeny are severely reduced
(Laouar et al., 2003). Specific transcription factors may
therefore govern the development of defined DC sub-
populations. However, no clear paradigm of develop-
mental hierarchies has evolved up to date.
We hypothesized that the analysis of transcription
factors upregulated during early steps of GM-CSF-
dependent DC maturation might elucidate master regu-
lators controlling DC differentiation. We made use of a
murine hematopoietic progenitor cell line (FDCP-mix)
permissive for in vitro DC differentiation and performed
transcriptional profiling analysis. Here, we report that
Gfi1, a zinc finger repressor molecule (Zweidler-McKay
et al., 1996) previously implicated in hematopoietic
stem cell homeostasis (Zeng et al., 2004; Hock et al.
2004), T cell (Schmidt et al., 1998; Karsunky et al.,
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v(Karsunky et al., 2002b; Hock et al. 2003), is critically
important in multiple stages of DC differentiation. i
l
GResults
c
GScreening of Gene Expression in Early DC
iDevelopment and Transcriptional
pActivity of the Gfi1 Locus
tTo identify transcription factors that control dendritic
tcell development, we performed transcriptional profil-
ping analyses of the murine hematopoietic progenitor
tcell line FDCP-mix that is permissive for DC differentia-
ution in the presence of GM-CSF (Schroeder et al., 2000)
s(Figure 1A). We reasoned that GM-CSF modulates a de-
lfined set of decisive transcription factors governing DC
differentiation during early differentiation steps. Total
RNA was therefore isolated at hours 0, 6, 24, and 48 of G
othis in vitro differentiation system, hybridized to Affy-
metrix GeneChips and analyzed by K-means cluster W
aanalysis. The most specific cluster for upregulated
genes was seen at 48h, containing a set of 91 genes, t
aincluding 6 transcription factors as presumable master
regulators of DC differentiation (Figure 1B). We focused p
mour further studies on Gfi1, a transcriptional repressor
with previously known regulatory roles in the hemato- D
fpoietic system (Zweidler-McKay et al., 1996; Schmidt
et al., 1998; Yücel et al., 2003; Karsunky et al., 2002b; I
dHock et al., 2003; Zeng et al., 2004; Hock et al., 2004)
and could confirm GM-CSF-dependent Gfi1 upregula- f
ttion by RT-PCR in FDCP-mix and primary Sca-1+lin−
hematopoietic progenitor cells (Figure 1C). To assess d
fthe physiological expression pattern of Gfi1, we made
use of a novel transgenic Gfi1:GFP knockin mutant u
mmouse in which one Gfi1 allele is replaced by the cDNA
of green fluorescent protein (Gfi1GFP/+) (Yücel et al., (
m2004). We determined the fluorescence intensity of vari-
ous CD11c+ DC subpopulations in lymphoid organs, d
fcomparing Gfi1GFP/+ and Gfi1+/+ mice. GFP expression
was detected at various intensities in CD11c+ DCs ob- 4
ltained from spleen and lymph nodes (Figure 1D). We
hypothesized that a heterogeneity in GFP expression p
iin vivo might depend on the activation status of DCs.
To address this question, we injected Gfi1GFP/+ mice i.p. i
awith LPS or stimulating anti-CD40 monoclonal antibod-
ies, sacrificed the mice 24 hr later and prepared single i
lcell suspensions from spleens and lymph nodes. Com-
pared to Gfi1GFP/+ DCs isolated from mice treated with m
iPBS, GFP expression was enhanced in Gfi1GFP/+ DCs
obtained from mice treated with LPS or anti-CD40 b
Gmonoclonal antibodies (Figure 1E), suggesting that Gfi1
expression is physiologically increased upon DC acti- i
tvation in vivo. The presence of Gfi1 protein in DCs was
also confirmed by Western blot analysis (Figure S2 in n
tthe Supplemental Data available with this article on-
line). Next, we analyzed the GFP expression profile in i
rDC development in vitro over time. We purified lineage-
depleted hematopoietic progenitor cells from Gfi1+/+, t
GGfi1GFP/+ and Gfi1GFP/GFP mice and incubated the cells
in the presence of either recombinant GM-CSF or re-
wcombinant Flt3L, two cytokines known to control my-
eloid and plasmacytoid DC differentiation, respectively. w
lAliquots of cells were analyzed for GFP expression bylow cytometry every 6–12 hr. Expression of GFP re-
ealed transcriptional activation of the Gfi1 locus dur-
ng early phases of DC development and a decline at
ater phases (Figure 1F). However, only in the case of
M-CSF we observed a marked increase in the fluores-
ence intensity during hours 48–72. In homozygous
fi1GFP/GFP progenitor cells, the levels of fluorescence
ntensity were generally higher and followed a defined
attern over time (Figure 1G), consistent with Gfi1 au-
oinhibition in DC development. To validate these in vi-
ro findings, we next assessed GFP expression in DC
rogenitor cells in Gfi1GFP/+ mice in vivo. We were able
o detect GFP expression in CD11c+MHC-classII− (Fig-
re 1H) and in Flt3+c-kit+lin− precursor DCs (Figure 1I)
uggesting that Gfi1 expression is physiologically regu-
ated in DC progenitor cells.
fi1−/− Mice Show Decreased Numbers
f DCs in Lymphoid Organs
e reasoned that the distinct expression profile of Gfi1
t early stages of DC development might have impor-
ant implications for the control of normal DC differenti-
tion. We enumerated CD11c+ DCs in single cell sus-
ensions from lymphoid organs in Gfi1−/− and Gfi1+/+
ice. In Gfi1−/− mice, the absolute numbers of CD11c+
Cs were significantly reduced in lymph nodes (w10-
old), spleen (w2-fold) and thymus (w20-fold) (Table 1).
n view of the GM-CSF-specific upregulation of Gfi1
uring early DC development, we were interested to
ind out whether Gfi1 may act as a lineage-specific
ranscription factor in “myeloid” versus “lymphoid” DC
evelopment and repeated the analysis with a specific
ocus on defined DC subpopulations. As shown in Fig-
re 2A, both conventional CD11c+B220− DCs and plas-
acytoid CD11c+B220+ DCs were reduced in spleen
upper panel) and lymph nodes (lower panel) of Gfi1−/−
ice. CD4+ and CD8+ DCs were present, albeit in re-
uced numbers. In spleens, a relative deficiency af-
ected mostly the CD4+ DC compartment (21% versus
0%, Figure 2B upper panel), whereas in peripheral
ymph nodes, mostly CD8high expressing cells ap-
eared reduced in frequency (7% in Gfi1−/− versus 21%
n Gfi1+/+, Figure 2B lower panel). Despite the variations
n the relative composition of the DC compartment, the
bsolute numbers of all DC subpopulations were signif-
cantly reduced in spleen (Figure 2C, upper panel),
ymph nodes (Figure 2C, intermediate panel) and thy-
us (Figure 2C, lower panel). In striking contrast to DCs
n lymphoid organs, we enumerated an increased num-
er of epidermal Langerhans cells (LCs, 40/mm2 in
fi1+/+ versus 92/mm2 in Gfi1−/−) (Figure 2D), suggest-
ng that Gfi1 does not play a critical role in the differen-
iation of LCs. We attempted to enhance in vivo DC
umbers by administration of recombinant Flt3L, a cy-
okine with known effects on DC progenitors. Interest-
ngly, in contrast to Gfi1+/+ mice, Gfi1−/− mice were un-
esponsive to Flt3L (Figure 2E), further suggesting
hat nonmyeloid DC development is also perturbed in
fi1−/− mice.
To assess whether the decreased number of DCs
as due to cell-autonomous or rather extrinsic effects,
e generated hematopoietic chimeras by transplanting
ineage-depleted hematopoietic progenitor cells ob-
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719Figure 1. Transcriptional Profiling Analysis and Transcriptional Activity of Gfi1 Locus
(A) Cell surface marker analysis of FDCP-mix cells after differentiation into DCs jl open histograms represent expression of indicated markers,
and shaded histograms represent isotype controls.
(B) Graphic and numeric representation of expression profile analysis of selected transcription factors upregulated in GM-CSF-treated FDCP-
mix cells. Relative expression (normalized to the median) is displayed as color (green = normalized expression level below, black = near to,
and red = above the median). Fold Change (hour 48 versus hour 0) is calculated by Affymetrix MAS 5.0, and p values are based on statistical
parameters as described for MAS 5.0 software. A comprehensive data set is available in Figure S1 and Array Express database (http://
www.ebi.ac.uk/arrayexpress).
(C) Quantification of Gfi1 mRNA expression by RT-PCR in FDCP-mix, and Sca1+lin− hematopoietic progenitor cells at hour 0 and 48 hr after
GM-CSF treatment. Shown are the mean values of duplicate samples. Data are representative of two independent experiments.
(D) Gfi1 expression in DCs. Gated CD11c+ cells in spleens and lymph nodes from Gfi1+/GFP mice were analyzed for GFP expression (open
histogram). Shaded histograms represent the autofluorescence of Gfi1+/+ DCs used as controls. In each experiment, organs from three to five
mice were pooled. Data are representative of three independent experiments.
(E) Enhanced transcriptional activity upon DC stimulation in vivo. Gfi1+/GFP mice were i.p. injected with LPS or anti-CD40 monoclonal antibod-
ies and DC fluorescence was measured by flow cytometry 24 hr later (open histograms). Shaded histograms represent the DC fluorescence
from PBS-treated Gfi1+/GFP mice.
(F and G) Gfi1 expression in DC development in vitro. Lineage marker-depleted bone marrow cells from Gfi1+/GFP mice (F) and Gfi1GFP/GFP
mice (G) were cultured either in the presence of GM-CSF and IL4 or Flt3L, respectively. Cells were harvested every 6–12 hr, and their
fluorescence was determined by FACS analysis. Shown is the specific geometric mean fluorescence intensity index calculated as follows:
GMFIi = GMFI(Gfi1+/GFP) – GMFI(Gfi1+/+). Results represent the average values of duplicate samples. Data are representative of three indepen-
dent experiments.
(H and I) Gfi1 expression in precursor DCs. Pooled bone marrow cells from three to five mice were analyzed for GFP expression in
CD11c+I-Ab− (H) and Lin−c-kit+Flt3+ cells (I). Open histograms represents GFP fluorescence in Gfi1+/GFP cells, and shaded histogram repre-
sents autofluorescence of Gfi1+/+ cells. Data are representative of three independent experiments.
Error bars indicate mean ± SEM.tained from Gfi1−/− and Gfi1+/+ (CD45.2) into irradiated
congenic recipient mice (CD45.1). Engraftment of donor
progenitor cells was confirmed by determining the level
of chimerism in the T cell, B cell, and myeloid lineage
(Figure S3). Eight weeks after transplantation, DCs of
donor origin developed only from Gfi1+/+ but not from
Gfi1−/− progenitor cells (Figure 2F), suggesting that the
nonhematopoietic environment did not contribute any
critical factors that could have caused the apparently
deficient DC development in Gfi1−/− mice.Gfi1 Controls DC Differentiation from Hematopoietic
Progenitor Cells
In principle, decreased DC numbers in Gfi1−/− mice
could be explained by increased turnover, aberrant dis-
tribution or decreased production of DCs. To assess
whether the lack of DCs was due to decreased pro-
duction, we next analyzed distinct progenitor popula-
tions. Hematopoietic stem cells (HSC), classically charac-
terized by absence of lineage markers and expression of
c-kit and Sca-1, were reduced by three to fourfold in
Immunity
720Table 1. Quantification of Dendritic Cells in Lymphoid Organs
Number of Cells per Organ Number of DCs per Organ
Gfi1+/+ Gfi1−/− Gfi1+/+ Gfi1−/− p Value
Spleen 18 ± 1 × 106 13 ± 4 × 106 2.7 ± 0.5 × 105 1.2 ± 0.4 × 105 <0.0168
Thymus 41 ± 9 × 106 7.0 ± 1 × 106 1.9 ± 0.1 × 105 0.1 ± 0.1 × 105 <0.000007
PLN 1.6 ± 0.4 × 106 2.7 ± 1.1 × 106 6.7 ± 0.5 × 103 0.5 ± 0.3 × 103 <0.00814
MLN 1.8 ± 0.5 × 106 6.0 ± 1 × 105 3.0 ± 0.7 × 103 0.2 ± 0.03 × 103 <0.00771Gfi1−/− mice (data not shown), confirming previously re- F
Cported findings (Zeng et al., 2004). HSC give rise to
committed progenitors, named CMP (lin−IL7R−c-kit+ cells preceding a DC precursor cell. The percentage of
Figure 2. Global Decrease of DCs in Lymphoid Organs of Gfi1−/− Mice
(A) Contour plot indicating relative decrease of conventional (CD11c+B220−) and plasmacytoid (CD11c+B220+) DC frequencies in spleens
(upper panel) and lymph nodes (lower panel, PLN). Flow cytometric analysis was performed on pooled mononuclear cells from five mice.
Shown is a representative experiment of four.
(B) Contour plots indicating relative decrease of splenic CD11c+CD4+ DC frequencies (upper panels) and relative decrease of CD11c+CD8+
DC frequencies in lymph nodes (lower panels). Cells were gated on the CD11c+ population.
(C) Absolute DC numbers according to classified DC subtypes. Gfi1−/− mice and Gfi1+/+ mice (n = 5) were sacrificed, and single cell suspen-
sions of spleens (upper panel), peripheral lymph nodes (middle panel), and thymi (lower panel) were pooled prior to enumeration. The absolute
number was determined based on the relative FACS profile and total number of cells. Shown is the average of two independent experiments.
(D) Quantification of epidermal Langerhans cells. Epidermal sheets from Gfi1−/− and Gfi1+/+ mice were stained with an APC-conjugated
monoclonal antibody reacting against I-Ab. Characteristic Langerhans cells were visualized in a fluorescence microscope (upper panels), and
their density was determined using calibrated grids (lower panel).
(E) Sustained defects of DC development in Gfi1−/− mice after Flt3L treatment. Gfi1−/− and Gfi1+/+ mice were treated (i.p.) with Flt3L for nine
consecutive days. Subsequently, cells were recovered from spleen and analyzed by FACS staining using anti-CD11c monoclonal antibodies.
The absolute number of DCs was determined based on the relative FACS profile and total number of cells.
(F) Contour plot documenting DC chimerism upon bone marrow transplantation. Lineage depleted bone marrow cells from Gfi1−/− mice and
Gfi1+/+ mice (CD45.2) were transplanted into lethally irradiated congenic recipient mice (CD45.1). Flow cytometric analysis of splenic DCs
reveals donor origin in Gfi1+/+ transplanted mice and recipient origin in Gfi1−/− transplanted mice after eight weeks of transplantation. Data
are representative of two independent experiments.
Error bars indicate mean ± SEM.cRγ+CD34+) and CLP (lin−IL7R+c-kit+). Both CMP and
LP contain Flt3+ cells that might represent progenitor
Gfi1 in DC Development
721CLP cells was found to be significantly reduced in the
bone marrow of Gfi1−/− mice (0.03% in Gfi1−/− versus
1% Gfi1+/+ (data not shown), also confirming previously
published results (Zeng et al., 2004; Hock et al., 2004).
Furthermore, CD11c+ MHC class II− DC precursor cells
in bone marrow (0.3% in Gfi1−/− versus 1% in Gfi1+/+,
Figure 3A) and peripheral blood (5% in Gfi1−/− versus 15%
in Gfi1+/+, Figure 3A) as well as DC progenitor cells char-
acterized by expression of c-kit+Flt+lin− (5% in Gfi1−/−
versus 18% in Gfi1+/+, Figure 3B) were significantly re-
duced in relative as well as in absolute numbers (Figure
3C). This suggests that the decreased numbers of DCs in
Gfi1−/− mice is primarily due to insufficient production.
Gfi1−/− DCs Show Functional Abnormalities
Revealing Distinct Effects in Maturation
and Activation Profiles
DC development is impaired in Gfi1−/− mice but not
completely abrogated. Since Gfi1 expression is upregu-
lated upon DC activation as documented by enhanced
GFP expression in Gfi1GFP/+ mice, we were interested
to assess whether the remaining DCs in Gfi1−/− mice
were characterized by functional defects. First, we ana-
lyzed the expression levels of MHC and costimulatory
molecules on DCs as markers of the maturation status
in lymphoid organs. In contrast to normal expression
levels of MHC class I, CD40, CD80, and CD86, we found
a significant reduction in MHC class II expression in all
DC subtypes in Gfi1−/− mice compared to Gfi1+/+ con-
trols (Figure 4A). To further assess whether DC matura-
tion could be triggered by a response to microbial com-
ponents or inflammatory cytokines, we injected Gfi1−/−
and Gfi1+/+ mice with anti-CD40 monoclonal antibodies
or LPS, respectively. Twenty-four hours after such stim-
ulation, splenic DCs were harvested, stained, and ana-
lyzed by flow cytometry. As shown in Figure 4B, Gfi1−/−
DCs were refractory to upregulation of the costimulary
molecules CD40, CD80, and CD86 by such treatment.
To assess whether these phenotypic abnormalities re-
present intrinsic rather than nonspecific secondary ef-
fects, we have generated DC-chimeric mice by trans-
planting lineage-depleted hematopoietic progenitor
cells from congenic CD45.1+Gfi+/+ mice into sublethally
irradiated (4.5Gy) CD45.2+Gfi1−/− recipient mice. Con-Figure 3. DC Progenitor Cell Analysis in
Gfi1−/− Mice
(A) Contour plots indicating decrease of
CD11c+I-Ab− precursor DC frequencies in
bone marrow (top panel) and peripheral
blood (bottom panel) of Gfi1−/− and Gfi1+/+
mice.
(B) Contour plot showing distribution of
B220− Flt3+ DC progenitor cell frequencies,
gated on lin− c-kit+ cells.
(C) Absolute DC progenitor cell numbers ac-
cording to classified subtypes. Gfi1−/− mice
and Gfi1+/+ mice were sacrificed, and single
cell suspensions of bone marrow and pe-
ripheral blood were prepared. The absolute
number was determined based on the rela-
tive FACS profile and total number of cells.
Error bars represent values obtained from
three mice.
Error bars indicate mean ± SEM.versely, CD45.2+Gfi1−/− progenitor cells were trans-
planted into sublethally irradiated CD45.1+Gfi1+/+ recip-
ient mice. Four weeks after transplantation, we
discriminated Gfi1−/− and Gfi1+/+ DCs in the spleens of
recipient animals based on the expression of CD45.1
and CD45.2. Upon in vivo challenge with anti-CD40
monoclonal antibodies, only Gfi1+/+ DCs showed nor-
mal upregulation of CD40 and CD86, while Gfi1−/− DCs
were refractory to maturation (Figure S4). These find-
ings suggest that the phenotypic alterations in Gfi1−/−
DCs are intrinsic and not due to an altered cytokine
milieu in Gfi1−/− mice.
To test whether a decreased level of DC maturation/
activation might be associated with decreased pro-
duction of inflammatory cytokines such as IL12, we
purified splenic DCs from Gfi1−/− and Gfi1+/+ mice and
stimulated the cells with TNFα or the Toll-like-receptors
ligands LPS (TLR2,4) and CpG (TLR9), respectively.
Surprisingly, we found that Gfi1−/− DCs showed a higher
baseline level of IL12 secretion that could not be further
increased upon stimulation, suggesting that maturation
(expression of MHC class II and costimulatory mole-
cules) and activation (expression of IL12) of DCs repre-
sent the result of at least partially independent and
distinct molecular events (Figure 4C). To further charac-
terize the function of Gfi1−/− DCs, we analyzed their ca-
pacity to present specific antigens to T cells. We puri-
fied splenic DCs from Gfi1−/− and Gfi1+/+ mice and
loaded them with Ova peptides SIINFEKL and Ova323–339,
two epitopes presented by MHC class I and II, respec-
tively. The cells were incubated with transgenic OT-I
and OT-II T cells recognizing Ova peptides in associa-
tion with MHC class I and class II. As shown in Figure
4D, Gfi1−/− DCs induced a significantly reduced OT-I
(upper panel) and OT-II (lower panel) T cell proliferation
in vitro. These data suggest that impaired antigen pre-
sentation is an intrinsic feature of Gfi1−/− DCs that can
not be readily explained by decreased MHC class II ex-
pression levels.
Gfi1 Is a Critical Cell-Intrinsic Modulator of DC
versus Macrophage Development
To further elucidate the mechanism of decreased DC
differentiation and function, we performed DC differen-
Immunity
722Figure 4. Phenotypic and Functional Abnormalities in Gfi1−/− DCs
(A) Decreased MHC class II expression in Gfi1−/− DCs. Mean fluorescence intensity after staining splenic and lymph node CD11c+ cells for
MHC class II expression. Shown is the average GMFI of two independent experiments, pooling organs from five mice. Data are representative
of six independent experiments.
(B) Histograms indicating that Gfi1−/− DCs are refractory to upregulate costimulatory molecules. Gfi1−/− and Gfi1+/+ mice were injected with
LPS or anti-CD40 monoclonal antibodies, respectively. Pooled DCs from three to five mice were analyzed for expression of CD40, CD80, and
CD86 (open histograms). Shaded histograms represent expression levels on DCs from PBS injected mice used as negative controls.
(C) Constitutive secretion of IL12 in Gfi1−/− DCs. Splenic DCs from Gfi1−/− and Gfi1+/+ mice were purified and stimulated with TNFα and the
TLR ligands CpG and LPS in duplicates. Shown is one representative experiments out of five. Error bars represent standard error in ELISA.
(D) Impaired antigen presentation in Gfi1−/− DCs. Splenic DCs from Gfi1−/− and Gfi1+/+ mice were loaded with peptides and used as antigen-
presenting cells to stimulate the proliferation of transgenic OT-I (upper panel) and OT-II cells (lower panel), respectively. T cell proliferation
was measured in triplicates by incorporation of 3H-Thymidine. Data are representative of three independent experiments.
Error bars indicate mean ± SEM.tiation assays in vitro. Lineage-depleted hematopoietic u
bprogenitor cells from Gfi1−/− and Gfi1+/+ mice were in-
cubated in the presence of GM-CSF and IL-4. Interest- a
ingly, in contrast to Gfi1+/+ progenitor cells, Gfi1−/− pro-
genitor cells did not differentiate into DC (Figure 5A). d
IInstead, in conditions classically permissive for “my-
eloid” DC differentiation, Gfi1−/− progenitor cells dif- d
rferentiated into macrophages, as assessed by immuno-
phenotype (Figure 5B), morphology (Figure 5C), and c
pcapacity to stimulate allogeneic T cell proliferation (Fig-
ure 5D). To exclude the possibility that variations in the h
tcellular composition of the lin-depleted hematopoietic
progenitor cell populations may account for differences c
ain the in vitro development, we isolated highly purified
Sca1+c-kit+lin− HSC and c-kit+Flt3+lin− DC progenitor b
rcells. None of these defined progenitor cells were able
to differentiate into dendritic cells (Figures 5E and S5A). g
wFurthermore, we assessed the potential of hematopoi-
etic progenitor cells to differentiate in response to (
aFlt3L, a cytokine with documented potential to induce
plasmacytoid DC development. As expected from pre- c
tvious in vivo data (Figure 2E), Gfi1−/− progenitor cells
did not differentiate into DCs in response to Flt3L (Fig- lres 5F and S5B), suggesting that the developmental
lock is not restricted to GM-CSF dependent effects
nd “myeloid” DC differentiation.
Since Gfi1−/− myeloid cells show an enhanced pro-
uction of cytokines (Karsunky et al., 2002b) and since
L6 has been described to direct macrophage over DC
evelopment in human cells (Chomarat et al., 2000), we
easoned that this diverted development might be se-
ondary to the cytokine milieu in culture. However, su-
ernatants from in vitro differentiation assays did not
ave any effect on DC differentiation of Gfi1+/+ progeni-
or cells (data not shown), suggesting that the defi-
iency of Gfi1−/− cells to develop into DC is a cell-
utonomous feature. This notion was further confirmed
y complementation experiments using Gfi1 encoding
etroviruses. We isolated Sca-1+lin− hematopoietic pro-
enitor cells from Gfi1−/− mice and transduced them
ith either a retrovirus encoding the marker gene GFP
SFβ91-GFP) or a bicistronic retrovirus encoding Gfi1
nd GFP (SFβ91-Gfi1-ires-GFP). We observed a signifi-
ant loss of viability of transduced cells upon Gfi1 gene
ransfer, presumably owing to nonphysiologically high
evels of retrovirus-mediated Gfi1 expression. However,
Gfi1 in DC Development
723Figure 5. Critical Modulation of DC versus Macrophage Development in Gfi1−/− Progenitor Cells
(A) Cell surface markers of hematopoietic progenitor cells differentiated in the presence of GM-CSF and IL4. Lineage-depleted hematopoietic
progenitor cells from Gfi1+/+ mice (upper panels) and Gfi1−/− mice (lower panels) were assessed for expression of characteristic DC markers
on day 8 of culture. Shaded histograms represent isotype fluorescence. The marker profile of differentiated Gfi1+/+ cells is typical of DCs,
whereas the marker profile of Gfi1−/− cells is characteristic of macrophages.
(B) Contour plot of GM-CSF differentiated cells showing CD11c+, CD11b+, F4/80+ DCs generated from Gfi1+/+ progenitor cells and CD11c−,
CD11b+, F4/80+ macrophages generated from Gfi1−/− progenitor cells.
(C) Phase contrast image of progeny cells derived from lineage-depleted bone marrow cells cultured in the presence of GM-CSF/IL4. Original
magnification was 100×.
(D) Allogeneic T cell response elicited by Gfi1+/+ and Gfi1−/− stimulator cells, respectively. Lineage-depleted bone marrow cells were cultured
in the presence of GM-CSF/IL4 for 8 days.
(E) Contour plot of cells differentiated from purified Sca1+c−kit+Lin− HSC in the presence of GM-CSF/IL4.
(F) Contour plot of cells differentiated from Lin− progenitor cells in the presence of Flt3-L.
(G and H) Contour plots indicating reconstitution of DC development upon retroviral gene transfer. Bone marrow progenitor cells were
transduced with retroviruses encoding GFP (left panel) and Gfi1-GFP (right panel), respectively. Cells were then differentiated in the presence
of GM-CSF. On day 8 of culture, CD11c expression was determined on GFP-transduced cells (G). For in vivo reconstitution assays, Sca1+lin−
cells from Gfi1−/− mice (CD45.2+) were transduced with retroviruses encoding either GFP (left panel) or Gfi1-GFP (right panel) and transplanted
into irradiated (4.5 Gy) congenic recipient mice (CD45.1+). GFP-positive splenocytes of recipient mice were analyzed for CD11c expression
by flow cytometry (H). Further experimental details are given in Figure S5C.
Error bars indicate mean ± SEM.in the surviving cells, 18% showed expression of the
DC marker CD11c, suggesting a partial reconstitution
of DC development in vitro (Figure 5G). More impor-
tantly, we also addressed reconstitution of the DC de-
velopment upon transplantation of retrovirus-trans-
duced HSC in vivo. Sca1+lin− HSC from Gfi1−/− mice
were transduced either with SFβ91-Gfi1-ires-GFP or
SFβ91-GFP and transplanted into irradiated recipient
mice. Upon reconstitution of the hematopoietic system,
the mice were sacrificed and analyzed for DC reconsti-
tution. Compared to mice transplanted with GFP-
expressing progenitor cells, we determined that the
percentage of CD11c+ cells among GFP-positive cells
was significantly higher in mice that had received Gfi1-
transduced progenitor cells (4.8%) compared to mice
that had received GFP-transduced progenitor cells
(0.2%, Figure 5H), suggesting that the retrovirus medi-ated expression of Gfi1 corrected the developmental
defect of Gfi1 deficient DCs.
Deficient DC Development in Gfi1−/− Mice
Is Associated with Decreased STAT3
Activation in Progenitor Cells
Previous in vitro data have shown that Gfi1 interacts
with PIAS3, a known inhibitor of STAT3 (Rödel et al.,
2000). STAT3 has recently emerged as an important me-
diator of DC differentiation (Laouar et al., 2003). We
therefore hypothesized that altered STAT3-signaling
may influence the developmental pathway of macro-
phage versus dendritic cell development. First, we doc-
umented a defect in early cytokine-dependent STAT3
signaling using Western blot analysis. Whereas Gfi1+/+
progenitor cells showed evidence of a rapid STAT3
phosphorylation response upon exposure to GM-CSF
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nin Gfi1−/− progenitor cells (Figure 6A). To further confirm
cytokine-dependent STAT3 activation in defined Gfi1−/− l
pDC progenitor cells, we analyzed the phosphorylated
STAT3 isoform in c-kit+Flt3+lin− cells by FACS. As p
cshown in Figure 6B, STAT3 phosphorylation was absent
in Gfi1−/− DC progenitor cells upon stimulation with
dGM-CSF and IL4. Next, we isolated lin− hematopoietic
progenitor cells from Gfi1+/+ and Gfi1−/− mice and deter- s
pmined nuclear translocation of activated STAT3 by
Western blot analysis, comparing cytosolic and nuclear f
Sprotein fractions. Whereas the specific band corre-
sponding to STAT3 protein in the cytosol was compara- m
pble in Gfi1−/− and Gfi1+/+ cells (Figure 6C, upper panel),Figure 6. Decreased STAT3 Activation in Gfi1−/− Progenitor Cells
(A) Western blot analysis. Lin-depleted bone marrow cells from Gfi1+/+ and Gfi1−/− mice were incubated in the presence of GM-CSF and IL-4. Cell
lysates were prepared at indicated time points. STAT3 (top panel) and phosphorylated STAT3-p(Ty705) (middle panel) was detected using
specific monoclonal antibodies. Monoclonal antibodies recognizing actin were used to confirm equal protein loading (bottom panel).
(B) Detection of phosphorylated STAT3-p(Ty705) in DC progenitors. Lin− BM cells of Gfi1+/+ and Gfi1−/− mice were stimulated in the presence
of GM-CSF and IL-4 for 5 min. Upon intracytoplasmic staining with an anti-STAT3-p(Ty705) monoclonal antibody, c-kit+Flt3+Lin− cells were
analyzed by flow cytometry. Open histograms represent cells treated with monoclonal antibodies recognizing phosphorylated STAT3-p, and
shaded histograms represent cells treated with the respective isotype control antibodies. Cells cultured in the absence of GM-CSF and IL-4
served as negative controls.
(C) Western blot analysis. Lin-depleted bone marrow cells from Gfi1+/+ and Gfi1−/− mice were incubated in the presence of GM-CSF and IL-4.
Cytosolic (upper panel) and nuclear protein fractions (lower panel) were purified at indicated time points. STAT3 was detected using a STAT3-
specific monoclonal antibody.
(D and E) Real-time PCR studies showing RNA levels of SOCS3 and PIAS3. Lin− bone marrow cells of Gfi1+/+ and Gfi1−/− mice were stimulated
with GM-CSF and IL-4. RNA was extracted at indicated time points and reverse transcribed into cDNA. The expression levels of SOCS3 RNA
(D) and PIAS3 RNA (E) were quantified by real-time PCR studies. Shown are the mean values of duplicate samples. Data are representative
of three independent experiments.
(F) Western blot analysis showing protein levels of SOCS3 and PIAS3. Lin-depleted bone marrow cells from Gfi1+/+ and Gfi1−/− mice were
incubated in the presence of GM-CSF and IL-4. Cell lysates were prepared at indicated time points. SOCS3 (upper panel) and PIAS3 (lower
panel) protein was detected using specific polyclonal antibodies. Actin was detected by specific monoclonal antibodies to confirm equal
protein loading.
(G) Contour plots indicating reconstitution of DC development upon retroviral gene transfer of constitutively active STAT3 (STAT3c). Bone
marrow progenitor cells were transduced with retroviruses encoding GFP (left panel) or STAT3c-GFP (right panel), respectively. Cells were
then differentiated in the presence of GM-CSF and IL-4. On day 8 of culture, CD11c expression was determined.
Error bars indicate mean ± SEM.e documented a significant reduction of STAT3 in the
uclear protein fraction at all time points (Figure 6C,
ower panel). This is consistent with impaired STAT3
hosphorylation and suggests that the amount of
hosphorylated STAT3 that can translocate into the nu-
leus is limited in the absence of Gfi1.
STAT3 signaling is negatively regulated by two well
efined STAT3 inhibitors, SOCS3 and PIAS3. We rea-
oned that decreased STAT3 phosphorylation in Gfi1−/−
rogenitor cells might be due to enhanced negative
eedback regulation of STAT3 specific kinases through
OCS3. It has been shown before that the SOCS3 pro-
oter contains Gfi1/Gfi1b binding sites and SOCS3 ex-
ression can be repressed by the Gfi1 homologue Gfi1b
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725(Jegalian and Wu, 2002). Strikingly, Gfi1−/− progenitor
cells showed higher RNA expression levels of SOCS3
(Figure 6D) and also of PIAS3 (Figure 6E) compared to
Gfi+/+ control. Consistent with these findings, we also
documented increased protein expression levels of
SOCS3 and PIAS3 in Gfi1−/− deficient progenitor cells
(Figure 6F). Finally, to provide direct evidence that de-
fective STAT3 phosphorylation and activation signaling
plays a role in the aberrant differentiation of Gfi1−/− den-
dritic progenitor cells, we performed rescue experi-
ments using a retroviral vector encoding a constitu-
tively active form of STAT3 (STAT3c). Upon expression
of this form of STAT3c in Gfi1−/− progenitor cells, we
were able to document a partial rescue of DC develop-
ment as measured by the differentiation of CD11c ex-
pressing DCs (Figure 6G).
Discussion
Using a transcriptional screening approach, we have
identified Gfi1 as a crucial transcription factor con-
trolling DC development and function. Gfi1 is a tran-
scriptional zinc finger repressor (Zweidler-McKay et al.,
1996) originally identified as a target gene for proviral
insertions leading to IL2 independent growth in a T cell
lymphoma line (Gilks et al., 1993). Gfi1 contains six
C2H2 zinc fingers and a transcriptional repressor do-
main (SNAG). Previous studies suggest that Gfi1 acts
as a protooncogene by accelerating T cell proliferation
and inhibiting apoptosis and cell cycle arrest (Grimes et
al., 1996; Karsunky et al., 2002a; Schmidt et al., 1998).
Furthermore, Gfi1 regulates proliferation and differenti-
ation of thymic and peripheral T cells (Doan et al., 2003;
Yücel et al., 2003; Zhu et al., 2002). More recently, a
more global role of Gfi1 in hematopoiesis has evolved.
Analysis of Gfi1−/− mice revealed an unexpected ab-
sence of mature neutrophils (Karsunky et al., 2002b;
Hock et al., 2003). Moreover, heterozygous mutations
in Gfi1 have been identified in rare patients with heredi-
tary neutropenia, suggesting that both loss of function
and dominant negative variants of Gfi1 block neutrophil
differentiation (Person et al., 2003). Furthermore, Gfi1 is
essential to restrict HSC proliferation and to preserve
HSC functional integrity (Hock et al., 2004; Zeng et al.,
2004).
Here, we provide evidence for yet another role of Gfi1
in controlling the complexity of hematopoietic stem cell
differentiation. Gfi1 deficiency leads to a global reduc-
tion in the number of DC precursors and their progeny
in bone marrow, thymus, spleen and lymph nodes, as
well as to incomplete DC maturation and function. Fur-
thermore, Gfi1 appears to be a key regulator of the lin-
eage decision process for precursors to differentiate
into DCs or macrophages.
Our original aim was to identify transcription factors
controlling specific subsets of DCs, in particular the de-
velopment of “myeloid” DCs as progeny of GM-CSF
treated HSCs. Previous reports have implicated a role
for PU.1 (Anderson et al., 2000; Guerriero et al., 2000),
RelB (Wu et al., 1998), and Ikaros C (Wu et al., 1997)
in the differentiation of CD11c+CD8α− “myeloid” DCs.
Unexpectedly, we found a global reduction of all DCs
in primary and secondary lymphoid organs in Gfi1 defi-cient mice, irrespective of CD8α expression. Although
our data do not exclude the existence of “myeloid”
DCs, the analysis of Gfi1−/− mice does not provide any
evidence for a distinct myeloid DC lineage. Interest-
ingly, Gfi1 deficiency did not perturb Langerhans cell
development. In that respect, Gfi1-deficient mice re-
semble RelB−/− (Wu et al., 1998) and IkarosC−/− mice
(Wu et al., 1997) that are characterized by a deficiency
of CD8α− DCs while epidermal LC appear normal. In
contrast, TGFβ−/− (Borkowski et al., 1996) and Id2-
knockout mice (Hacker et al., 2003) show a complete
lack of epidermal LCs, while other DC subpopulations
are at least partially preserved, supporting the notion
of a distinct LC lineage. Thus, the analysis of Gfi1−/−
mice provides additional evidence for a dissociation of
DC development in peripheral lymphoid organs and
epidermal Langerhans cells.
The decisive factors controlling macrophage versus
DC development remain elusive. Various cytokines,
such as IL6, TNFα, and interferon-γ induce DC versus
macrophage differentiation in vitro (Chomarat et al.,
2000; Chomarat et al., 2003; Delneste et al., 2003).
Other studies suggest that the Notch ligand Delta-1 in-
hibits macrophage differentiation while permitting DC
differentiation (Ohishi et al., 2001). However, analysis of
cytokine knockout mice has not yet revealed any spe-
cific factor that dissociates DC and macrophage devel-
opment. Intracellular mechanisms responsible for DC
versus macrophage development are currently not
known. In mice doubly deficient for two NFκB subunits
(p50−/−RelA−/−), GM-CSF-dependent DC development
is severely reduced whereas M-CSF dependent macro-
phage development appears normal (Ouaaz et al.,
2002). In our study, both Flt3L and GM-CSF, two cyto-
kines inducing DC development in wildtype hematopoi-
etic stem cells, drive Gfi1−/− hematopoietic progenitor
cells into macrophage differentiation. Thus, Gfi1 is a
unique factor governing DC versus macrophage devel-
opment in vitro. In this respect, Gfi1-deficient hemato-
poiesis is reminiscent of STAT3-deficient hematopoisis
that is characterized by increased cell autonomous
proliferation of cells of the myeloid lineage (Welte et
al., 2003) associated with a defect of DC development
(Laouar et al., 2003).
The precise biochemical function of Gfi1 is at present
under active investigation. Gfi1 shares the same DNA
binding and a SNAG (Snail and Gfi1 family of proteins)
repression domain with its homologue, Gfi1B (Grimes
et al., 1996). Both factors have redundant and unique
biological roles in controlling hematopoiesis (Hock et
al., 2003; Saleque et al., 2002; Karsunky et al., 2002b;
Doan et al., 2003). As a transcription factor, Gfi1 dis-
plays activity in the nucleus as a DNA binding transcrip-
tional repressor. In addition, there is evidence for an-
other function of Gfi1 that does not require DNA binding
(Rödel et al., 2000). This is mediated by a direct physi-
cal interaction of Gfi1 with PIAS3 (protein inhibitor of
activated STAT3), a specific inhibitor of STAT3. Using a
STAT3-dependent reporter gene assay, earlier studies
have suggested that Gfi1 can increase STAT3 signaling
by overcoming the inhibitory effects mediated by PIAS3
(Rödel et al., 2000). Consistent with this finding would
be an impairment of STAT3 signaling in Gfi1−/− cells.
Indeed, here we confirm and extend this observation
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726into a functional model of DC differentiation and pro- l
vide unequivocal evidence that in the absence of Gfi1, a
STAT3 phosphorylation and hence very likely its signal- a
ing is significantly reduced in early DC progenitor cells. D
Independent evidence for a critical role of STAT3 in i
DC development has recently also been proposed by (
others (Laouar et al., 2003). In these studies STAT3 acti- c
vation was found to be a critical checkpoint of Flt3L h
regulated DC development (Laouar et al., 2003). In the n
absence of STAT3, the transition of CLP and CMP to t
Flt3+ DC precursors was severely impaired, while GM- s
CSF-induced DC differentiation in vitro was not altered r
in this system. This is in contrast to the situation de- d
scribed here where the almost complete lack of in- p
ducible STAT3 phosphorylation in the absence of Gfi1 c
correlates with the abrogation of both Flt3L and GM- a
CSF-dependent DC differentiation. This suggests that h
deficient STAT3 signaling is not the only mechanism ex- t
plaining the phenotype of Gfi1−/− hematopoiesis and p
that other parallel pathways must exist supporting DC T
differentiation that are affected by the lack of Gfi1. o
In its classical function, Gfi1 acts as a transcriptional l
repressor and influences the expression of a multitude u
of downstream effector genes. The recent identification N
of a large number of Gfi1 target gene candidates il- a
lustrated the complexity of Gfi1-dependent pathways f
(Duan and Horwitz, 2003). Gfi1 binds to functionally di- t
verse sets of genes in myeloid cells such as JAK3, IL8,
c-Myc, and members of the C/EBP family, as was t
shown by chromatin immunoprecipitation (Duan and a
Horwitz, 2003). Interestingly, Gfi1 autoregulates its own p
transcription in primary lymphoid cells (Doan et al., m
2004; Yücel et al., 2004). Our experiments indicate a w
similar phenomenon in DC progenitor cells, since the o
transcriptional activity of the Gfi1 locus is higher in
Gfi1Gfp/Gfp progenitor cells compared to Gfi1Gfp/+ cells.
Similar GFP expression patterns in response to Flt3L S
and GM-CSF in the Gfi1Gfp/Gfp progenitor cells may re-
Sflect a common regulatory role of Gfi1-mediated sup-
Ppressive effects in “myeloid” and “lymphoid” DC devel-
copment.
c
Previous reports have proposed that DC maturation
and DC activation have to be seen as molecularly dis-
Atinct events, phenotypically characterized by (1) upreg-
ulation of surface expression of MHC class II and the T
costimulatory molecules CD40, CD80, and CD86, and g
(2) production of inflammatory cytokines (e.g., IL12) K
(Kaisho and Akira, 2001; Kobayashi et al., 2003; Ouaaz
et al., 2002). DC maturation is primarily induced upon R
signaling via Toll-like-receptors (TLR) and CD40. Gfi1−/− R
DCs show decreased expression of MHC class II and A
Pdecreased upregulation of costimulatory receptors
upon stimulation with LPS and anti-CD40 monoclonal
Rantibodies, a phenotype consistent with impaired DC
maturation. TRAF6 has emerged as a point of con-
Avergence for both TLR- and CD40-mediated signaling
Tcascades, linking both pathways to NFκB activation.
v
TRAF6−/− deficient DCs show decreased maturation c
and thus resemble Gfi1−/− DCs (Kobayashi et al., 2003). A
However, in contrast to Gfi1−/− DCs, TRAF6−/− DCs are W
characterized by decreased cytokine production (Ko- p
bayashi et al., 2003). The analysis of mice deficient for a
the expression of defined factors regulating NFκB have A
dprovided more insights into the complex network regu-ating DC activation and cytokine production. For ex-
mple, mice doubly deficient in the NF-kB subunits p50
nd RelA exhibit a severe reduction in CD8+ and CD8−
Cs, while mice doubly deficient in p50 and cRel show
mpaired CD40L-mediated survival and IL12 production
Ouaaz et al., 2002). Furthermore, DCs from mice defi-
ient in the negative NF-κB regulator NFκB2 show en-
anced expression of activation markers but produce
ormal levels of cytokines (Speirs et al., 2004). In con-
rast to these models however, Gfi1−/− DCs reveal a dis-
ociated phenotype characterized by decreased matu-
ation and increased activation. In view of our results
ocumenting decreased STAT3 activation in Gfi1−/− DC
rogenitors, it is tempting to speculate that the in-
reased cytokine secretion is related to deficient STAT3
ctivation in DCs. Targeted STAT3 deficiency in the
ematopoietic system is associated with chronic en-
erocolitis, aberrant inflammation and lethality to septic
eritonitis (Matsukawa et al., 2003; Takeda et al., 1999).
his pathology is associated with increased expression
f inflammatory cytokines. No data have been pub-
ished about maturation of STAT3−/− DCs, but overstim-
lated innate immunity is associated with enhanced
FκB activity in STAT3−/− hematopoietic cells (Welte et
l., 2003). Thus, Gfi1−/− mice offer a model system to
urther dissect the mechanisms controlling DC matura-
ion and activation.
In conclusion, our results demonstrate a key role for
he transcriptional repressor Gfi1 in DC development
nd function. Our studies provide insights into the com-
lex hierarchical network controlling DC differentiation,
aturation and activation, and reveal specific path-
ays that might ultimately be important for the design
f rational DC therapies.
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